ID   ABD12_HUMAN             Reviewed;         398 AA.
AC   Q8N2K0; A6NED4; A6NJ90; A8K450; B4DE71; Q5T710; Q5T711; Q96CR1;
AC   Q9BX05; Q9NPX7; Q9UFV6;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2003, sequence version 2.
DT   12-APR-2017, entry version 131.
DE   RecName: Full=Monoacylglycerol lipase ABHD12 {ECO:0000305};
DE            EC=3.1.1.23 {ECO:0000269|PubMed:22969151};
DE   AltName: Full=2-arachidonoylglycerol hydrolase {ECO:0000305};
DE   AltName: Full=Abhydrolase domain-containing protein 12 {ECO:0000305};
GN   Name=ABHD12 {ECO:0000312|HGNC:HGNC:15868};
GN   Synonyms=C20orf22 {ECO:0000312|HGNC:HGNC:15868};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Cerebellum, Kidney, and Ovarian carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 152-398 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   INVOLVEMENT IN PHARC.
RX   PubMed=20797687; DOI=10.1016/j.ajhg.2010.08.002;
RA   Fiskerstrand T., H'mida-Ben Brahim D., Johansson S., M'zahem A.,
RA   Haukanes B.I., Drouot N., Zimmermann J., Cole A.J., Vedeler C.,
RA   Bredrup C., Assoum M., Tazir M., Klockgether T., Hamri A., Steen V.M.,
RA   Boman H., Bindoff L.A., Koenig M., Knappskog P.M.;
RT   "Mutations in ABHD12 cause the neurodegenerative disease PHARC: An
RT   inborn error of endocannabinoid metabolism.";
RL   Am. J. Hum. Genet. 87:410-417(2010).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF SER-246; ASP-333 AND HIS-372.
RX   PubMed=22969151; DOI=10.1194/jlr.M030411;
RA   Navia-Paldanius D., Savinainen J.R., Laitinen J.T.;
RT   "Biochemical and pharmacological characterization of human alpha/beta-
RT   hydrolase domain containing 6 (ABHD6) and 12 (ABHD12).";
RL   J. Lipid Res. 53:2413-2424(2012).
RN   [9]
RP   INVOLVEMENT IN PHARC.
RX   PubMed=22938382; DOI=10.1186/1750-1172-7-59;
RA   Eisenberger T., Slim R., Mansour A., Nauck M., Nurnberg G.,
RA   Nurnberg P., Decker C., Dafinger C., Ebermann I., Bergmann C.,
RA   Bolz H.J.;
RT   "Targeted next-generation sequencing identifies a homozygous nonsense
RT   mutation in ABHD12, the gene underlying PHARC, in a family clinically
RT   diagnosed with Usher syndrome type 3.";
RL   Orphanet J. Rare Dis. 7:59-59(2012).
RN   [10]
RP   FUNCTION, AND INVOLVEMENT IN PHARC.
RX   PubMed=24027063; DOI=10.1002/humu.22437;
RA   Chen D.H., Naydenov A., Blankman J.L., Mefford H.C., Davis M., Sul Y.,
RA   Barloon A.S., Bonkowski E., Wolff J., Matsushita M., Smith C.,
RA   Cravatt B.F., Mackie K., Raskind W.H., Stella N., Bird T.D.;
RT   "Two novel mutations in ABHD12: expansion of the mutation spectrum in
RT   PHARC and assessment of their functional effects.";
RL   Hum. Mutat. 34:1672-1678(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Lysophosphatidylserine (LPS) lipase that plays a key
CC       role in the central nervous system. Represents a major LPS lipase
CC       in the brain (By similarity). May also have a 2-
CC       arachidonoylglycerol (2-AG) hydrolase activity and act as a
CC       regulator of endocannabinoid signaling pathways.
CC       {ECO:0000250|UniProtKB:Q99LR1, ECO:0000269|PubMed:22969151,
CC       ECO:0000269|PubMed:24027063}.
CC   -!- CATALYTIC ACTIVITY: Hydrolyzes glycerol monoesters of long-chain
CC       fatty acids. {ECO:0000269|PubMed:22969151}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=117 uM for 2-arachidonoyglycerol
CC         {ECO:0000269|PubMed:22969151};
CC         Vmax=42 nmol/min/mg enzyme toward 2-arachidonoyglycerol
CC         {ECO:0000269|PubMed:22969151};
CC       pH dependence:
CC         Optimum pH is 7.2-9 with 2-arachidonoyglycerol as substrate.
CC         {ECO:0000269|PubMed:22969151};
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q99LR1};
CC       Single-pass membrane protein {ECO:0000250|UniProtKB:Q99LR1}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8N2K0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N2K0-2; Sequence=VSP_009097;
CC       Name=3;
CC         IsoId=Q8N2K0-3; Sequence=VSP_037372;
CC   -!- PTM: Glycosylated. {ECO:0000250|UniProtKB:Q99LR1}.
CC   -!- DISEASE: Polyneuropathy, hearing loss, ataxia, retinitis
CC       pigmentosa, and cataract (PHARC) [MIM:612674]: A slowly
CC       progressive neurologic disorder with a variable phenotype
CC       resembling Refsum disease. Clinical features include sensorineural
CC       hearing loss, visual problems related to cataracts, retinitis
CC       pigmentosa, pes cavus, ataxic and/or spastic gait disturbances
CC       with a progressive sensorimotor peripheral neuropathy. Other
CC       features include hyporeflexia, hyperreflexia, extensor plantar
CC       responses. {ECO:0000269|PubMed:20797687,
CC       ECO:0000269|PubMed:22938382, ECO:0000269|PubMed:24027063}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the serine esterase family. {ECO:0000305}.
CC   -!- CAUTION: A family suffering from Polyneuropathy, hearing loss,
CC       ataxia, retinitis pigmentosa, and cataract (PHARC) was initially
CC       clinically diagnosed with Usher syndrome type 3. Reexamination of
CC       one affected member of this family revealed ataxia but not
CC       polyneuropathy, demonstrating the phenotypic heterogeneity in
CC       PHARC and the need for careful neurological assessments to
CC       distinguish this disease from other neuropathic disorders
CC       (PubMed:22938382). {ECO:0000305|PubMed:22938382}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK075023; BAC11357.1; -; mRNA.
DR   EMBL; AK290815; BAF83504.1; -; mRNA.
DR   EMBL; AK293495; BAG56982.1; -; mRNA.
DR   EMBL; AL121772; CAI23474.1; -; Genomic_DNA.
DR   EMBL; AL353812; CAI23474.1; JOINED; Genomic_DNA.
DR   EMBL; AL121772; CAI23475.1; -; Genomic_DNA.
DR   EMBL; AL353812; CAI23475.1; JOINED; Genomic_DNA.
DR   EMBL; AL353812; CAI13762.1; -; Genomic_DNA.
DR   EMBL; AL121772; CAI13762.1; JOINED; Genomic_DNA.
DR   EMBL; AL353812; CAI13763.1; -; Genomic_DNA.
DR   EMBL; AL121772; CAI13763.1; JOINED; Genomic_DNA.
DR   EMBL; CH471133; EAX10089.1; -; Genomic_DNA.
DR   EMBL; BC014049; AAH14049.1; -; mRNA.
DR   EMBL; AL117442; CAB55927.1; -; mRNA.
DR   CCDS; CCDS13172.1; -. [Q8N2K0-2]
DR   CCDS; CCDS42857.1; -. [Q8N2K0-1]
DR   PIR; T17237; T17237.
DR   RefSeq; NP_001035937.1; NM_001042472.2. [Q8N2K0-1]
DR   RefSeq; NP_056415.1; NM_015600.4. [Q8N2K0-2]
DR   UniGene; Hs.441550; -.
DR   ProteinModelPortal; Q8N2K0; -.
DR   BioGrid; 117541; 7.
DR   IntAct; Q8N2K0; 14.
DR   STRING; 9606.ENSP00000365725; -.
DR   BindingDB; Q8N2K0; -.
DR   ChEMBL; CHEMBL5516; -.
DR   SwissLipids; SLP:000001043; -.
DR   ESTHER; human-ABHD12; AlphaBeta_hydrolase.
DR   MEROPS; S09.054; -.
DR   iPTMnet; Q8N2K0; -.
DR   PhosphoSitePlus; Q8N2K0; -.
DR   BioMuta; ABHD12; -.
DR   DMDM; 38604894; -.
DR   EPD; Q8N2K0; -.
DR   MaxQB; Q8N2K0; -.
DR   PaxDb; Q8N2K0; -.
DR   PeptideAtlas; Q8N2K0; -.
DR   PRIDE; Q8N2K0; -.
DR   DNASU; 26090; -.
DR   Ensembl; ENST00000339157; ENSP00000341408; ENSG00000100997. [Q8N2K0-1]
DR   Ensembl; ENST00000376542; ENSP00000365725; ENSG00000100997. [Q8N2K0-2]
DR   GeneID; 26090; -.
DR   KEGG; hsa:26090; -.
DR   UCSC; uc002wuq.4; human. [Q8N2K0-1]
DR   CTD; 26090; -.
DR   DisGeNET; 26090; -.
DR   GeneCards; ABHD12; -.
DR   HGNC; HGNC:15868; ABHD12.
DR   HPA; HPA026866; -.
DR   MalaCards; ABHD12; -.
DR   MIM; 612674; phenotype.
DR   MIM; 613599; gene.
DR   neXtProt; NX_Q8N2K0; -.
DR   OpenTargets; ENSG00000100997; -.
DR   Orphanet; 171848; Polyneuropathy - hearing loss - ataxia - retinitis pigmentosa - cataract.
DR   PharmGKB; PA25738; -.
DR   eggNOG; KOG1552; Eukaryota.
DR   eggNOG; COG1073; LUCA.
DR   GeneTree; ENSGT00390000006625; -.
DR   HOVERGEN; HBG051152; -.
DR   InParanoid; Q8N2K0; -.
DR   KO; K13704; -.
DR   OMA; KYPKGLD; -.
DR   OrthoDB; EOG091G0QYO; -.
DR   PhylomeDB; Q8N2K0; -.
DR   TreeFam; TF315122; -.
DR   Reactome; R-HSA-426048; Arachidonate production from DAG.
DR   ChiTaRS; ABHD12; human.
DR   GenomeRNAi; 26090; -.
DR   PRO; PR:Q8N2K0; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000100997; -.
DR   CleanEx; HS_ABHD12; -.
DR   ExpressionAtlas; Q8N2K0; baseline and differential.
DR   Genevisible; Q8N2K0; HS.
DR   GO; GO:0032281; C:AMPA glutamate receptor complex; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0047372; F:acylglycerol lipase activity; IDA:UniProtKB.
DR   GO; GO:0004622; F:lysophospholipase activity; IDA:BHF-UCL.
DR   GO; GO:0046464; P:acylglycerol catabolic process; IDA:UniProtKB.
DR   GO; GO:0007628; P:adult walking behavior; IEA:Ensembl.
DR   GO; GO:0046475; P:glycerophospholipid catabolic process; IDA:BHF-UCL.
DR   GO; GO:0052651; P:monoacylglycerol catabolic process; IDA:BHF-UCL.
DR   GO; GO:0006660; P:phosphatidylserine catabolic process; IEA:Ensembl.
DR   GO; GO:0010996; P:response to auditory stimulus; IEA:Ensembl.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR026605; ABHD12.
DR   InterPro; IPR022742; Hydrolase_4.
DR   PANTHER; PTHR12277:SF104; PTHR12277:SF104; 1.
DR   Pfam; PF12146; Hydrolase_4; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cataract; Complete proteome; Deafness;
KW   Glycoprotein; Hydrolase; Membrane; Neuropathy; Polymorphism;
KW   Reference proteome; Retinitis pigmentosa; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    398       Monoacylglycerol lipase ABHD12.
FT                                /FTId=PRO_0000079413.
FT   TOPO_DOM      1     74       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q99LR1}.
FT   TRANSMEM     75     95       Helical. {ECO:0000250|UniProtKB:Q99LR1}.
FT   TOPO_DOM     96    398       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q99LR1}.
FT   COMPBIAS     20     25       Poly-Ser.
FT   COMPBIAS     26     29       Poly-Ala.
FT   ACT_SITE    246    246       Nucleophile.
FT                                {ECO:0000305|PubMed:22969151}.
FT   ACT_SITE    333    333       Charge relay system.
FT                                {ECO:0000305|PubMed:22969151}.
FT   ACT_SITE    372    372       Charge relay system.
FT                                {ECO:0000305|PubMed:22969151}.
FT   VAR_SEQ      11     48       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_037372.
FT   VAR_SEQ     387    398       EFLGKSEPEHQH -> PQQGPGSSPDPSMWSELV (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_009097.
FT   VARIANT     349    349       A -> T (in dbSNP:rs746748).
FT                                /FTId=VAR_050630.
FT   MUTAGEN     246    246       S->A: Loss of 2-arachidonoyglycerol
FT                                hydrolase activity.
FT                                {ECO:0000269|PubMed:22969151}.
FT   MUTAGEN     333    333       D->N: Loss of 2-arachidonoyglycerol
FT                                hydrolase activity.
FT                                {ECO:0000269|PubMed:22969151}.
FT   MUTAGEN     372    372       H->A: Loss of 2-arachidonoyglycerol
FT                                hydrolase activity.
FT                                {ECO:0000269|PubMed:22969151}.
FT   CONFLICT    359    359       V -> I (in Ref. 1; BAF83504).
FT                                {ECO:0000305}.
FT   CONFLICT    376    376       Y -> C (in Ref. 1; BAC11357).
FT                                {ECO:0000305}.
SQ   SEQUENCE   398 AA;  45097 MW;  E21425C1412B5607 CRC64;
     MRKRTEPVAL EHERCAAAGS SSSGSAAAAL DADCRLKQNL RLTGPAAAEP RCAADAGMKR
     ALGRRKGVWL RLRKILFCVL GLYIAIPFLI KLCPGIQAKL IFLNFVRVPY FIDLKKPQDQ
     GLNHTCNYYL QPEEDVTIGV WHTVPAVWWK NAQGKDQMWY EDALASSHPI ILYLHGNAGT
     RGGDHRVELY KVLSSLGYHV VTFDYRGWGD SVGTPSERGM TYDALHVFDW IKARSGDNPV
     YIWGHSLGTG VATNLVRRLC ERETPPDALI LESPFTNIRE EAKSHPFSVI YRYFPGFDWF
     FLDPITSSGI KFANDENVKH ISCPLLILHA EDDPVVPFQL GRKLYSIAAP ARSFRDFKVQ
     FVPFHSDLGY RHKYIYKSPE LPRILREFLG KSEPEHQH
//
